Companies enhance leadership in molecular diagnostics by pairing Sherlock’s advanced CRISPR, synthetic biology and AI technologies with Sense’s instrument-free diagnostic hardware and rapid molecular amplification chemistries for faster path to commercialization ...
Instrument-Free Veros™ COVID-19 Produces Highly Accurate Molecular Results in about 15 minutes BOSTON, USA, OXFORD & CAMBRIDGE, UK, AMSTERDAM, NETHERLANDS, — November 22, 2022 — Global molecular diagnostics innovator Sense Biodetection (Sense) today announced...
Veros™ COVID-19 Produces Highly Accurate Molecular Results in about 15 minutes BOSTON, USA, OXFORD & CAMBRIDGE, UK and TORONTO, CANADA — November 10, 2022 — Global molecular diagnostics innovator Sense Biodetection (Sense) today announced it has entered into...
Instrument-Free Veros™ COVID-19 Produces Lab-Quality Molecular Results in about 15 minutes BOSTON, USA, OXFORD & CAMBRIDGE, U.K. — Santiago, Chile — November 2, 2022 — Global molecular diagnostics innovator Sense Biodetection (Sense) today announced it has...
Instrument-Free Veros™ COVID-19 Produces Lab-Quality Molecular Results in about 15 minutes BOSTON, USA, OXFORD & CAMBRIDGE, UK and Brisbane, Australia — October 5, 2022 — Global molecular diagnostics innovator Sense Biodetection (Sense) today announced it has...
Lab-Quality, Instrument-Free Veros™ COVID-19 Molecular Test Available Now BOSTON, USA and OXFORD & CAMBRIDGE, UK — September 1, 2022 — Global molecular diagnostics innovator, Sense Biodetection (Sense), today announced it has entered into a strategic agreement...